期刊文献+

主动脉内球囊反搏治疗急性心肌梗死急诊冠状动脉介入治疗术后无复流现象的临床研究 被引量:17

Effect of intraaortic balloon pumping on no-reflow phenomenon in emergency percutaneous coronary intervention
原文传递
导出
摘要 目的:探讨主动脉内球囊反搏(IABP)在急性心肌梗死(AMI)急诊冠状动脉介入治疗(PCI)术后无复流(NR)现象中的治疗作用。方法:分析自2006-01-2010-08期间因AMI行PCI术后NR患者30例资料,采用单双日法分组方法将其中16例运用IABP治疗,其余未用IABP的14例为对照组,观察术后10d内心肌损伤标志物、脑钠肽(BNP)及血管活性物质恢复情况。心肌损伤标志物包括肌红蛋白、肌酸激酶同工酶(CK-MB)、肌钙蛋白I(cTnI);血管活性物质指标包括肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)、肾上腺素(E)、去甲肾上腺素(NE);治疗10d后应用彩色超声心动图测量患者左房内径、左室内径、左室射血分数(LVEF);并随访3个月、6个月左房内径、左室内径、LVEF变化情况。结果:IABP治疗组患者血管活性物质及心肌损伤标志物指标时间-浓度曲线显示指标下降明显快于对照组,2组间血管活性物质及心肌损伤标志物与对照组相比,2组下降幅度差异有统计学意义(P<0.05);IABP组BNP峰值较对照组提前,IABP治疗组BNP指标时间-浓度曲线显示指标下降明显快于对照组,2组间BNP指标下降与对照组相比差异无统计学意义(P>0.05);超声心动图测量2组患者10d、3个月及6个月时左房内径、左室内径及LVEF差异有统计学意义(P<0.05)。结论:IABP能够加速降低AMI急诊PCI术后发生NR患者升高的交感神经系统、RAS系统激素及心肌损伤标志物的水平;使BNP峰值提前并改善10d、3个月及6个月时左房内径、左室内径及射血分数值。 Objective:To investigate the effect of intra-aortic balloon pumping(IABP) on no-reflow phenomenon in emergency percutaneous coronary intervention(PCI).Method:Clinical data of 30 acute myocardial infarction patients after PCI with angiographic no-reflow phenomenon were retrospectively analyzed between January 2006 and August 2010.16 patients were performed IABP.Other 14 patients served as control group.Observe differences of cardiac structure,brain natriuretic peptide and cardiac ventricle systolic function between two groups,and several Vasoactive substances including plasma renin activity(PRA),aldosterone(ALD),angiotensin Ⅱ(ANGⅡ),norepinephrine(NE) and epinephrine(E) as well as Cardiac injury markers(MYO,CK-MB,cTnI) in both groups on the days of 1,2,3,5,7,10 after the different interventions.In addition,cardiac structure and cardiac ventricle systolic function including Left atrium medial diameter(LAMD),left ventricular medial diameter(LVMD),left ventricular ejection fraction(LVEF) was evaluated after 10 days,3 months,6 months.Finally,statistics was taken to analyze the data.Result:The time-concentration curves demonstrated that vasoactive substances and cardiac injury markers in IABP group decreased obviously earlier than control group,and there was significant difference in the decrease extent between these two groups(P0.05).Compared with control group,BNP in IABP group reached peak earlier and decreased earlier with significant differences.However,there was no significant difference in the decrease extent between these two groups(P0.05).UCG demonstrated that there were significant differences in LAMD,LVMD,LVEF of 10 days,3 months,6 months between these two groups(P0.05).Conclusion:IABP had effects on prognostic value in AMI patients underwent PCI with angiographic no-reflow phenomenon.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第4期294-298,共5页 Journal of Clinical Cardiology
关键词 急性心肌梗死 主动脉内球囊反搏 无复流现象 经皮冠状动脉介入治疗 acute myocardial infarction intra-aortic balloon pumping angiographic no-reflow phenomenon percutaneous coronary intervention
  • 相关文献

参考文献16

  • 1SHARMA S K,DANGASG,MEHRAN R,et al.Risk factors for the development of slow during rotational coronary atherectomy[J].Am Cardiol,1997,80:219-222.
  • 2杨跃进.经皮冠状动脉介入治疗中无再流的诊断、治疗和预防[J].中华心血管病杂志,2004,32(7):662-664. 被引量:57
  • 3Kiyoaki Maekawa,Kenji Kawamoto,Soichiro Fuke,et al.Effects of intraaortic balloon pumping on angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction[J].Circ J,2006,70:37-43.
  • 4KLONE R A,GANOTE C E,JENNINGSR B.The no-reflow phenomenon after temporary coronary occlusion in the dog[J].J Clin Invest,1974,54:1496-1508.
  • 5袁军,黄从新,王风,林英忠,徐广马,周丽珍.主动脉内球囊反搏对急诊冠脉介入术后无复流的治疗作用观察[J].广西医学,2007,29(5):660-662. 被引量:16
  • 6LUCIANO C,AMADO,DARA L.Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study[J].JACC,2004,April 7,2004:1291-1298.
  • 7TOYOTA E,GOTO M,NAKAMOTO H,et al.Endothelium-derived nitric oxide enhances the effect of intraaortic balloon pumping on diastolic coronary flow[J].Ann thorac surg,1999,67:1254-1261.
  • 8ACKINS C J,ANO S,SEYEDL N,et al.Cardiac mast cell-derived rennin promotes local angiotensin formation,norepinephrine release,and arrhythmiasin ischemia/reperfusion[J].J Clin Invest,2006,116:1063-1070.
  • 9RICHARDS A M,NICHOLLS M G,YANDLE T G.Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction.The Christchurch Cardioendocrine Research Group[J].Heart,1999,81:114-120.
  • 10杨延民,王旭,邵一兵,崔维刚,吴茂源,高华安.血栓抽吸治疗急性ST段抬高型心肌梗死前后神经内分泌因子水平的变化[J].中国介入心脏病学杂志,2008,16(2):77-81. 被引量:10

二级参考文献18

  • 1石湘芸,董林旺.急性心肌梗塞和内皮素关系的临床与基础研究[J].中华内科杂志,1993,32(6):384-387. 被引量:21
  • 2Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captoril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med, 1992,327:669-677.
  • 3Beltrame JF,Limaye SB,Wuttke I, et al, Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J,2003, 146: 84-90.
  • 4Abbo KM, Dooris M, Glazier S, et al. Features and outcome of noreflow after percutaneous coronary intervention. Am J Cardiol, 1995, 75:775-752.
  • 5Topol EJ, Yadav JS. Recoginition of the importance of embohzation in atherosclerotic vascular disease. Circulation, 2000, 101: 570-580.
  • 6Giugliano GR, Kuntz Richard, Popma JJ, et al. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a dlstal occlusion embolic protection device. Am J Cardiol,2005 ,95 :173-177.
  • 7Orrego PS, Delgado A, Piccalo G,et al. Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: single-center experience. Catheter Cardiovasc Interv, 2003,60 : 152-158.
  • 8Li SS, Lam CW, So YC, et al. The use of a distal occlusion balloon protection device in acute coronary syndrome. Int Cardiol, 2003,92:281-284.
  • 9Gibbons R J, Abrams J, Chstterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation ,2003,107 : 149-158.
  • 10Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology, Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22: 1527-1560.

共引文献78

同被引文献147

引证文献17

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部